- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/66 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 233/66
Total number of patents in this class: 79
10-year publication summary
|
2
|
5
|
7
|
7
|
4
|
5
|
9
|
1
|
11
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Design Therapeutics Inc. | 55 |
4 |
| Blade Therapeutics, Inc. | 15 |
3 |
| Universite Laval | 708 |
3 |
| Merck Patent GmbH | 5725 |
2 |
| California Institute of Technology | 4042 |
2 |
| Assembly Biosciences, Inc. | 101 |
2 |
| Daiichi Sankyo Company, Limited | 1894 |
2 |
| Fisheries Research Agency | 9 |
2 |
| Ramot at Tel-Aviv University Ltd. | 1538 |
2 |
| Sanofi Pasteur | 375 |
2 |
| Suzhou Kintor Pharmaceuticals, Inc. | 64 |
2 |
| Symrise AG | 1838 |
2 |
| The Trustees of Princeton University | 1260 |
2 |
| Vichem Chemie Kutató Kft. | 13 |
2 |
| William Marsh Rice University | 1066 |
2 |
| Cropnosys (India) Private Limited | 7 |
2 |
| F. Hoffmann-La Roche AG | 7838 |
1 |
| Janssen Pharmaceutica N.V. | 3175 |
1 |
| Abbvie Inc. | 1844 |
1 |
| Arrow Therapeutics Limited | 8 |
1 |
| Other owners | 39 |